Table 3.

Cost-effectiveness of L-APPE in our study patients

Parameter	Endoloop (n = 60)	Hem-o-lok (n = 60)	Stapler (n = 60)	P-value	Total (n = 180)
Direct costs (Euro, mean ± SD)	1705.4 ± 500.9	1624.9 ± 768	2120 ± 435	< 0.001	1816.1 ± 624.3
Payments from health insurance companies (Euro, mean ± SD)	1603.7 ± 227	1619.8 ± 355.6	1910.6 ± 350	< 0.001	1711.8 ± 346
Profit (Euro, mean ± SD)	− 98.6 ± 487.4	− 5.1 ± 761	− 209.3 ± 412	0.0072	− 104.3 ± 579.2